Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Biocientifica Receives CE Mark

By HospiMedica staff writers
Posted on 17 Jan 2002
The Diffuplate product range of Biocientifica (Buenos Aires, Argentina) has received the CE Mark, the company has
announced.

The CE Mark guarantees that the products are in compliance with European in vitro diagnostic standards and directives. More...
Diffuplate is a comprehensive name for a number of about 25 different in-vitro diagnostic products intended to measure specific proteins in biologic fluids by quantitative radial immunodiffusion. These assays are designed to aid the diagnosis of infectious, autoimmune, and nutritional diseases as well as cancer and coagulation disorders.

The company's products are manufactured at a GMP-approved facility in Buenos Airies and are exported to 25 countries in Europe, Africa, and the Americas. Biocientifica intends to obtain the CE mark for the rest of its products by December 2002.




Related Links:
Biocientifica

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.